Insider Ownership Activity for W. Anthony Vernon

SEC Forms 3/4/5 positions, issuer links, and transaction evidence for this reporting owner.

Linked issuers

3

Largest position

NovoCure Ltd

Disclosed value

$3.25M

Transaction activity

Available

Ownership signals CIK-linked ownership evidence from parsed SEC filings. 1 signal
Reporting-owner positions (Forms 3/4/5)

Forms 3/4/5 connect reporting owners to issuers, positions, and transactions disclosed to the SEC. They are filing-backed ownership signals, not a complete capitalization table.

Estimated position value

3/4/5
$3.25M

Estimated from parsed Forms 3/4/5 when filings include enough share and price data.

Linked issuers

3/4/5
3

Distinct issuers connected to this reporting owner in parsed SEC filings.

Latest parsed filing

SEC
05 Jun 2026

Most recent reporting-owner filing date in the parsed SEC record.

NovoCure Ltd (NVCR)

Filing-backed value: $2.38M · 12-month value change: -$46.4K · Role: Director

+1 more

Additional issuer positions are listed below.

How to read Forms 3/4/5 positions
  • Reported values are filing-backed estimates from parsed SEC Forms 3/4/5 when the filing includes enough share and price data.
  • Use this as reporting-owner context, not as a full capitalization table or a public-float ownership breakdown.
Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
New York, NY
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
Steven Robbins, as attorney in fact for Vernon, W. Anthony
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Follow Filing Activity

Follow W. Anthony Vernon and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Reported issuer positions for W. Anthony Vernon

NVCR Forms 3/4/5

NovoCure Ltd

Relationship
Director
Holdings value
$2,382,543
Past year net change
-$46,445
Change %
-1.9%
Report period
03 Jun 2026
MKC, MKC-V Forms 3/4/5

MCCORMICK & CO INC

Relationship
Director
Holdings value
$869,009
Past year net change
Change %
Report period
15 Feb 2026
NUVB Forms 3/4/5

Nuvation Bio Inc.

Relationship
Director
Holdings value
Past year net change
Change %
Report period
21 May 2026

Recent insider transactions for W. Anthony Vernon

Sym Company Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .